National HealthCare Net Income
| NHC Stock | USD 162.75 1.18 0.73% |
As of the 9th of February, National HealthCare secures the Mean Deviation of 1.41, risk adjusted performance of 0.2034, and Downside Deviation of 1.8. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National HealthCare, as well as the relationship between them.
National HealthCare Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5577 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 117.4 M | 123.3 M | |
| Net Income Applicable To Common Shares | 117.2 M | 123.1 M | |
| Net Income From Continuing Ops | 117.4 M | 73.7 M | |
| Net Income Per Share | 5.96 | 6.26 | |
| Net Income Per E B T | 0.67 | 0.55 |
National | Net Income | Build AI portfolio with National Stock |
Analyzing National HealthCare's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing National HealthCare's current valuation and future prospects.
Latest National HealthCare's Net Income Growth Pattern
Below is the plot of the Net Income of National HealthCare over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in National HealthCare financial statement analysis. It represents the amount of money remaining after all of National HealthCare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is National HealthCare's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National HealthCare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 102.09 M | 10 Years Trend |
|
Net Income |
| Timeline |
National Net Income Regression Statistics
| Arithmetic Mean | 68,173,935 | |
| Geometric Mean | 60,270,201 | |
| Coefficient Of Variation | 49.11 | |
| Mean Deviation | 24,488,379 | |
| Median | 59,300,000 | |
| Standard Deviation | 33,480,804 | |
| Sample Variance | 1121T | |
| Range | 120.9M | |
| R-Value | 0.59 | |
| Mean Square Error | 776T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | 3,927,944 | |
| Total Sum of Squares | 17935.4T |
National Net Income History
Other Fundumenentals of National HealthCare
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
National HealthCare Net Income component correlations
National Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for National HealthCare is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Net Income. Since National HealthCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National HealthCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National HealthCare's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National HealthCare. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.08) | Dividend Share 2.5 | Earnings Share 6.48 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between National HealthCare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National HealthCare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, National HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
National HealthCare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to National HealthCare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of National HealthCare.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in National HealthCare on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding National HealthCare or generate 0.0% return on investment in National HealthCare over 90 days. National HealthCare is related to or competes with Acadia Healthcare, Mednax, Select Medical, Aveanna Healthcare, Addus HomeCare, Brookdale Senior, and Lifestance Health. National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living ... More
National HealthCare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure National HealthCare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess National HealthCare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.8 | |||
| Information Ratio | 0.1978 | |||
| Maximum Drawdown | 9.28 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 4.32 |
National HealthCare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for National HealthCare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as National HealthCare's standard deviation. In reality, there are many statistical measures that can use National HealthCare historical prices to predict the future National HealthCare's volatility.| Risk Adjusted Performance | 0.2034 | |||
| Jensen Alpha | 0.3972 | |||
| Total Risk Alpha | 0.2664 | |||
| Sortino Ratio | 0.2077 | |||
| Treynor Ratio | 0.6458 |
National HealthCare February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2034 | |||
| Market Risk Adjusted Performance | 0.6558 | |||
| Mean Deviation | 1.41 | |||
| Semi Deviation | 1.4 | |||
| Downside Deviation | 1.8 | |||
| Coefficient Of Variation | 407.71 | |||
| Standard Deviation | 1.89 | |||
| Variance | 3.56 | |||
| Information Ratio | 0.1978 | |||
| Jensen Alpha | 0.3972 | |||
| Total Risk Alpha | 0.2664 | |||
| Sortino Ratio | 0.2077 | |||
| Treynor Ratio | 0.6458 | |||
| Maximum Drawdown | 9.28 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 4.32 | |||
| Downside Variance | 3.23 | |||
| Semi Variance | 1.97 | |||
| Expected Short fall | (1.59) | |||
| Skewness | 0.0447 | |||
| Kurtosis | 0.9722 |
National HealthCare Backtested Returns
National HealthCare appears to be very steady, given 3 months investment horizon. National HealthCare has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for National HealthCare, which you can use to evaluate the volatility of the firm. Please exercise National HealthCare's Mean Deviation of 1.41, downside deviation of 1.8, and Risk Adjusted Performance of 0.2034 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, National HealthCare holds a performance score of 14. The company secures a Beta (Market Risk) of 0.7, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National HealthCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding National HealthCare is expected to be smaller as well. Please check National HealthCare's skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether National HealthCare's current price movements will revert.
Auto-correlation | 0.67 |
Good predictability
National HealthCare has good predictability. Overlapping area represents the amount of predictability between National HealthCare time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of National HealthCare price movement. The serial correlation of 0.67 indicates that around 67.0% of current National HealthCare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 90.69 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
National Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, National HealthCare reported net income of 102.09 M. This is 70.09% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 82.12% higher than that of the company.
National Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National HealthCare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National HealthCare could also be used in its relative valuation, which is a method of valuing National HealthCare by comparing valuation metrics of similar companies.National HealthCare is currently under evaluation in net income category among its peers.
National HealthCare Current Valuation Drivers
We derive many important indicators used in calculating different scores of National HealthCare from analyzing National HealthCare's financial statements. These drivers represent accounts that assess National HealthCare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National HealthCare's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.0B | 1.0B | 1.4B | 1.7B | 1.5B | 1.6B | |
| Enterprise Value | 1.1B | 1.1B | 1.4B | 1.8B | 1.6B | 1.7B |
National HealthCare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National HealthCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National HealthCare's managers, analysts, and investors.Environmental | Governance | Social |
National Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0495 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 2.34 B | ||||
| Shares Outstanding | 15.52 M | ||||
| Shares Owned By Insiders | 18.81 % | ||||
| Shares Owned By Institutions | 59.15 % | ||||
| Number Of Shares Shorted | 294.24 K | ||||
| Price To Earning | 22.85 X | ||||
| Price To Book | 2.38 X | ||||
| Price To Sales | 1.67 X | ||||
| Revenue | 1.3 B | ||||
| Gross Profit | 578.46 M | ||||
| EBITDA | 182.53 M | ||||
| Net Income | 102.09 M | ||||
| Cash And Equivalents | 76.12 M | ||||
| Cash Per Share | 14.19 X | ||||
| Total Debt | 214.77 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 67.87 X | ||||
| Cash Flow From Operations | 107.3 M | ||||
| Short Ratio | 4.50 X | ||||
| Earnings Per Share | 6.48 X | ||||
| Target Price | 6.15 | ||||
| Number Of Employees | 14.96 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 1.96 B | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 752.19 M | ||||
| Working Capital | 189.61 M | ||||
| Current Asset | 164.61 M | ||||
| Current Liabilities | 114.08 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 2.89 % | ||||
| Net Asset | 1.52 B | ||||
| Last Dividend Paid | 2.5 |
About National HealthCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National HealthCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National HealthCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National HealthCare. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.08) | Dividend Share 2.5 | Earnings Share 6.48 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between National HealthCare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National HealthCare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, National HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.